Georgia's Online Cancer Information Center

Find A Clinical Trial

A Prospective Observational Study to Estimate the Incidence of Febrile Neutropenia (FN) Among Subjects With Non-myeloid Malignancies at High Risk for FN and Receiving Neulasta® (pegfilgrastim) Onpro® kit or Other Physician Choice Options for Prophylaxis of Febrile Neutropenia

Status
Active
Cancer Type
Breast Cancer
Lung Cancer
Non-Hodgkin Lymphoma
Prostate Cancer
Trial Phase
Eligibility
, Male and Female
Study Type
Other
NCD ID
Protocol IDs
AMG 011 20170758 (primary)
Study Sponsor
Amgen
NCI Full Details
Georgia CORE

 

Hearts and Minds Dedicated to Improving Cancer Care

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.